MoneyWorks4Me

Hester Biosciences informs about outcome of board meeting

28 Oct 2021 Evaluate
Hester Biosciences has informed that Board of Directors, in its Meeting held today, have approved the followings: Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30 September 2021, as recommended by Audit Committee; Appointment of Priya Gandhi as a Whole-time Director of the Company for the period for 5 (Five) years, subject to approval of members; Appointment of Ameet Desai as an Independent Director of the Company for the period of 5 (Five) years, subject to approval of members. Also attached the approved standalone and consolidated unaudited financial results and limited review reports; and Press Release issued in this regard.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

2413.65 -45.60 (-1.85%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: